Brant Point Investment Management’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.83M Sell
45,000
-13,631
-23% -$1.1M 0.47% 57
2026
Q1
$4.42M Sell
58,631
-9,049
-13% -$666K 0.57% 46
2025
Q4
$4.59M Sell
67,680
-12,500
-16% -$781K 0.56% 57
2025
Q3
$4.57M Sell
80,180
-14,573
-15% -$863K 0.49% 49
2025
Q2
$5.25M Sell
94,753
-28,855
-23% -$1.35M 0.55% 37
2025
Q1
$5.4M Sell
123,608
-59,071
-32% -$2.57M 0.65% 35
2024
Q4
$7.86M Sell
182,679
-7,321
-4% -$330K 0.98% 19
2024
Q3
$8.49M Buy
190,000
+54,374
+40% +$2.25M 0.93% 21
2024
Q2
$5.22M Buy
+135,626
New +$5.17M 0.47% 46

Other funds holding DBD

Brant Point Investment Management's DBD Position: Q2 2026 in Review

Brant Point Investment Management reduced its Diebold Nixdorf (DBD) stake by 23% in Q2 2026, selling an estimated $1.1M and leaving 45,000 shares worth $3.83M. The position accounts for 0.47% of the portfolio, ranked #57.

Brant Point Investment Management first reported a position in DBD in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.49M in Q3 2024. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Brant Point Investment Management held 45,000 shares of Diebold Nixdorf worth $3.83M as of Q2 2026.
  • Brant Point Investment Management sold 13,631 Diebold Nixdorf shares in Q2 2026, an estimated $1.1M.
  • Diebold Nixdorf made up 0.47% of Brant Point Investment Management's portfolio in Q2 2026, its #57 holding.
  • Brant Point Investment Management first reported a position in Diebold Nixdorf in Q2 2024 and has held it in 9 quarters since.
  • Brant Point Investment Management's Diebold Nixdorf position peaked at $8.49M in Q3 2024.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Brant Point Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.